A Novel Intergenic Region (chr2: 30,316,870)-ALK Fusion in a Patient with Lung Adenocarcinoma Responding to Crizotinib Combined with Pemetrexed Treatment: A Case Report

Zhou D, Ying J, Hu S, Li J, Liu H

OncoTargets and Therapy 2024, 17:261-265

Published Date: 27 March 2024